Latest multiple sclerosis Stories
The 2014 LDN at the MEET is being organised by the charity the LDN Research Trust in the UK and Mark’s Dugs in the US.
Researchmoz presents this most up-to-date research on "EpiCast Report: Multiple Sclerosis - Epidemiology Forecast to 2023".
HAYWARD, Calif., May 28, 2014 /PRNewswire/ -- Questcor Pharmaceuticals, Inc.
ROCKLAND, Mass., May 28, 2014 /PRNewswire/ -- EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced today that Rebif(®) (interferon beta-1a) data will be presented at the 2014
The Notus Sports Golf Challenge at Birdwood Golf Course on June 19 will raise funds for the Blue Ridge Chapter of the National Multiple Sclerosis Society.
On World MS Day, May 28, the National MS Society asks people with MS from around the world to share their wishes and how they hope to access their best lives while providing exciting updates on
On World MS Day, May 28, the National MS Society asks people with MS from around the world to share their wishes on how they hope to access their best lives NEW YORK, May 27, 2014 /PRNewswire-USNewswire/
MISSISSAUGA, ON, May 27, 2014 /CNW/ - Biogen Idec Canada announces today that TECFIDERA(TM) (dimethyl fumarate) is now available for reimbursement in Ontario through the Ontario Public Drugs
RnRMarketResearch.com adds “EpiCast Report Multiple Sclerosis – Epidemiology Forecast to 2023” to its store.
There is “an increased frequency of latent EBV-infected B cells in MS,” according to a study published in Acta Neurologica Scandinavica on March 31, 2014 (1).
More Images (1 images) »